The pertinence of genetic screening in gamete donors
DOI:
https://doi.org/10.18597/rcog.180Keywords:
Genetic screening, gamete donor, infertility, azoospermia, cystic fibrosis, spinal muscular atrophy, fragile X syndromeAbstract
Introduction: A major concern for pairs undergoing assisted reproduction treatment with donated gametes is the possibility of acquiring infectious diseases or transmitting genetic diseases to their offspring. Some reports have been based on the legislation of each country and each centre's experience referring to the type of genetic infectious and/or psychological evaluation which gamete donors must undergo. There is no specific law in Colombia about assisted reproduction and/ or gamete donor techniques; also, there is no clarity about whether donors should be genetically evaluated and which type of test should be used for this.
Objective: This document was aimed at making a reflection about the pertinence of genetically evaluating gamete donors by characterising the main genetic conditions prevailing in the Colombian population, base genetic alteration and the method currently being used for genetic diagnosis.
Conclusion: It was concluded that a clear national protocol must be developed about genetic evaluation in gamete-donating patients; this should also be done in assisted reproduction centres.
Author Biography
Claudia J. Serrano-Serrano
References
Garrido N, Zuzuarregui JL, Meseguer M, Simón C, Remohí J, Pellicer A. Sperm and oocyte donor selection and management: experience of a 10 year follow-up of more than 2100 candidates. Hum Reprod 2002;17:3142-8.
Daar J, Brzyski R. Genetic screening of sperm and oocyte donorsethical and policy implications. JAMA 2009;302:1702-4.
Sims CA, Callum P, Ray M, Iger J, Falk RE. Genetic testing of sperm donors: survey of current practices. Fertil Steril 2010;1:126-9.
Decreto 1546 de 1998 (agosto 4). Diario Oficial 43.357, del 6 de agosto de 1998, Ministerio de Salud Píblica, Leyes 9 de 1979 y 73 de 1988, en cuanto a la obtención, donación, preservación, almacenamiento, transporte, destino y disposición final de componentes anatómicos y los procedimientos para trasplante de los mismos en seres humanos, y se adoptan las condiciones mínimas para el funcionamiento de las Unidades de Biomedicina Reproductiva, Centros o similares.
Molina O, Blanco J, Vidal F. Deletions and duplications of the 15q11-q13 region in spermatozoa from Prader-Willi syndrome fathers. Mol Hum Reprod 2010;16:320-8.
Maron BJ, Lesser JR, Schiller NB, Harris KM, Brown C, Rehm HL. Implications of hypertrophic cardiomyopathy transmitted by sperm donation. JAMA 2009;302:1681-4.
Callum P, Iger J, Ray M, Sims CA, Falk RE. Outcome and experience of implementing spinal muscular atrophy carrier screening on sperm donors. Fertil Steril 2010;94:1912-4.
Callum P, Urbina MT, Falk RE, Alvarez-Diaz JA, Benjamin I, Sims CA. Spinal muscular atrophy (SMA) after conception using gametes from anonymous donors: recommendations for the future. Fertil Steril 2010;93:1006.e1-2.
U.S. Food and Drug Administration (FDA). FDA Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products. Disponible en: http://www.fda.gov/BiologicsBloodVaccines/TissueTissueProducts/RegulationofTissues/ucm150485.htm
Practice Committee of American Society for Reproductive Medicine; Practice Committee of Society for Assisted Reproductive Technology. 2008 Guidelines for gamete and embryo donation: a Practice Committee report. Fertil Steril 2008;5 Suppl:S30-44.
Páez P, Suárez-Obando F, Zarante I. Enfermedades de origen genético en pacientes pediátricos hospitalizados en la Provincia de Ubaté, Colombia. Salud Pública 2008;10:414-22.
Bernal J, Suárez F. La carga de la enfermedad genética en Colombia, 1996-2025. Univ Med Bogotá (Colombia) 2005;49:12-28.
Zarante I, Franco L, López C, Fernández N. Frecuencia de malformaciones congénitas. Evaluación y pronóstico de 52.744 nacimientos en cuatro ciudades colombianas. Biomédica 2010;30:65-71.
Schaeffer A, Chung J, Heretis K, Wong A, Ledbetter DH, Lese Martin C. Comparative genomic hybridization-array analysis enhances the detection of aneuploidies and submicroscopic imbalances in spontaneous miscarriages. Am J Hum Genet 2004;74:1168-74.
Chen CP, Wu PC, Lin CJ, Chern SR, Tsai FJ, Lee C, et al. Unbalanced reciprocal translocation at amniocentesis. Taiwanese J Obstet Gynecol 2011;50:48-57.
Vandeweyer G, Kooy RF. Balanced translocations in mental retardation. Hum Genet 2009;126:133-47.
Health Centre for Genetics Education. Autosomal Recessive Inheritance. Disponible en: http://www.genetics.edu.au/Information/Genetics-Fact-Sheets/Autosomal-Recessive-Inheritance-FS8/view
Cystic Fibrosis Mutation Database. Disponible en: http://www.genet.sickkids.on.ca/cftr/StatisticsPage.html
Lay-Son G, Repetto G. Genética y fibrosis quística: desde el gen CFTR a los factores modificadores. Neumología pediátrica 2010;5:4-9.
Malambo D, Gómez D, Veloza L, Arbeláez J, Gómez C. Algunos aspectos hereditarios y ambientales en casos de fibrosis quística en la ciudad de Cartagena (Colombia). Salud Uninorte. Barranquilla (Col) 2008;24:10-22.
Ortigosa L. Fibrosis quística: aspectos diagnósticos. Colombia Médica 2007;38:Supl 1.
Dequeker E, Stuhrmann M, Morris MA, Casals T, Castellani C, Claustres M, et al. Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders--updated European recommendations. Eur J Hum Genet 2009;17:51-65.
Vásquez C, Aristizábal R, Daza W. Fibrosis quística en Colombia. Neumología pediátrica 2010;5:44-50.
Keyeux G, Rodas C, Bienvenu T, Garavito P, Vidaud D, Sanchez D, et al. CFTR mutations in patients from Colombia: implicactions for local and regional molecular diagnosis programs. Hum Mut 2003;22:1-7.
Ogino S, Wilson R. Spinal muscular atrophy: molecular genetics and diagnostics. Expert Rev Mol Diagn 2004;4:15-29.
Monani U. Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease. Neuron 2004;48:885-96.
Akutsu T, Nishio H, Sumino K, Takeshima Y, Tsuneishi S, Wada H, et al. Molecular genetics of spinal muscular atrophy: contribution of the naip gene to clinical severity. Kobe J Med Sci 2002;48:25-31.
McAndrew PE, Parsons W, Simard LR, Rochette C, Ray PN, Mendell JR, et al. Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet 1997;60:1411-22.
Stewart H, Wallace A, McGaughran J, Mountford R, Kingston H. Molecular diagnosis of spinal muscular atrophy. Arch Dis Child 1998;78:531-5.
Steinberg MH, Adewoye AH. Modifier genes and sickle cell anemia. Curr Opin Hematol 2006;13:131-6.
Clark BE, Thein SL. Molecular Diagnosis of Haemoglobin Disorders. Clin Lab Haematol 2004; 26:159-76.
Troxler H, Kleinert P, Schmugge M, Speer O. Advances in hemoglobinopathy detection and identification. Adv Clin Chem 2012;57:1-28.
Health Centre for Genetics Education. X-Linked Inheritance. Disponible en: http://www.genetics.edu.au/Information/Genetics-Fact-Sheets/X-Linked-Inheritance-FS10/view
Rousseau F, Rouillard P, Morel ML, Khandjian EW, Morgan K. Prevalence of carriers of premutation-size alleles of the FMR1 gene--and implications for the population genetics of the fragile X syndrome. Am J Hum Genet 1995;57:1006-18.
Bennett CE, Conway GS, Macpherson JN, Jacobs PA, Murray A. Intermediate sized CGG repeats are not a common cause of idiopathic premature ovarian failure. Hum Reprod 2010;25:1335-8.
Lyon E, Laver T, Yu P, Jama M, Young K, Zoccoli M, et al. A simple, high-throughput assay for Fragile X expanded alleles using triple repeat primed PCR and capillary electrophoresis. J Mol Diagn 2010;12:505-11.
Kremer EJ, Pritchard M, Lynch M, Yu S, Holman K, Baker E, et al. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 1991;252:1711-4.
Chatterjee S, Maitra A, Kadam S, Patel Z, Gokral J, Meherji P. CGG repeat sizing in the FMR1 gene in Indian women with premature ovarian failure. Reprod Biomed Online 2009;19:281-6.
Gleicher N, Weghofer A, Oktay K, Barad D. Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve. Reprod Biomed Online 2009;19:385-90.
Lledo B, Guerrero J, Ortiz JA, Morales R, Ten J, Llacer J, et al. Intermediate and normal sized CGG repeat on the FMR1 gene does not negatively affect donor ovarian response. Hum Reprod 2012; 27:609-14.
Strom CM, Crossley B, Redman JB, Buller A, Quan F, Peng M, et al. Molecular testing for Fragile X Syndrome: lessons learned from 119,232 tests performed in a clinical laboratory. Genet Med 2007;9:46-51.
Mercuri E, Muntoni F. The ever-expanding spectrum of congenital muscular dystrophies. Ann Neurol 2012;72:9-17.
Silva C, Fonseca D, Restrepo CM, Contreras NC, Mateus HE. Deleciones en el gen de la distrofina en 62 familias colombianas: correlación genotipo- fenotipo para la distrofia muscular de Duchenne y Becker. Colomb Med 2004;35:191-8.
Lovering RM, Porter NC, Bloch RJ. The muscular dystrophies: from genes to therapies. Physther 2005;85:1372-88.
Bakker E, Hofker MH, Goor N, Mandel JL, Wrogemann K, Davies KE, et al. Prenatal diagnosis and carrier detection of Duchenne muscular dystrophy with closely linked RFLP´s. Lancet 1985;1:655-8.
How to Cite
Downloads
Downloads
Published
Issue
Section
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
